Author(s): Guy Glover and Manu Shankar-Hari
A good outcome depends on prompt diagnosis, adequate fluid resuscitation, timely administration of appropriate initial antibiotic therapy, and drainage of any infected collection. An overview of the principles of clinical management is shown in Box 35.2.
Manage patients with sepsis according to a sepsis bundle, for example Surviving Sepsis Campaign Bundle (Box 35.2) or the United Kingdom Sepsis 6.
Red flag signs:
Presence of one or more of red flag signs is an emergency. Refer to the Critical Care Outreach Team for further management of these patients in an intensive care or high-dependency unit.
Hypotension and Organ Dysfunction
Management requires invasive monitoring and critical care expertise.
Arterial and central venous monitoring will be required if the patient is in septic shock or once in the ICU but placement should not delay initial priorities.
The first priority is adequate fluid resuscitation, using a balanced crystalloid (e.g. Hartmann's solution). This should be guided by a clinical assessment of the circulation and tissue perfusion. A CVP of +812 (1215 mmHg in mechanically ventilated patients) has been proposed as a target to guide fluid resuscitation, although more sophisticated measures may also be used which include response to passive leg raising, echocardiography or cardiac output monitoring.
If the patient remains hypotensive despite adequate fluid correction, start norepinephrine (dose range 0.051.0µgm/kg/min). This must be administered via a central line. Aim for mean arterial pressure >65 mmHg. The goal is to restore tissue perfusion. Monitor with:
If evidence of end organ hypoperfusion persists, perform a bedside echocardiogram and / or measure the cardiac output. Consider measures to improve oxygen delivery, such as transfusion of packed red cells or adding inotropic therapy, for example dobutamine.
Respiratory support
Mechanical ventilation in sepsis is indicated for:
The principles of ARDS management include:
Acute kidney injury (AKI) is common in sepsis and is associated with a worse outcome. The principles of treatment of AKI in sepsis are:
Source control
When a persisting source of sepsis exists it is unlikely that antibiotics alone will be effective. Consider empyema, appendicitis, pyelonephrosis, necrotizing fasciitis. Indwelling cannulae, especially central venous lines, should be removed (and the tip sent for culture)
Antibiotic de-escalation and stewardship
Once the pathogenic organism is known the spectrum should be narrowed. Change to oral therapy once the patient is improved and apyrexial for >24 h. Most guidelines recommend a 710 day course but a shorter course (e.g. 5 days) may be safe if clinical resolution has occurred. In some situations, prolonged courses are necessary, for example infective endocarditis, lung abscess or bone infection: seek advice from a microbiologist. To avoid the development of resistance and the development of health-care associated infection (e.g. Clostridium difficile diarrhoea) antibiotics should not be overused:
Patients with neutrophil counts <0.5×109/L are at high risk of bacterial infection, particularly from Gram-negative rods and Staphylococcus aureus and epidermidis. If the neutropenic patient has a single temperature >38°C, or two spikes of fever of >37.5°C during a 24-h period, the likely cause is bacterial infection and empiric broad spectrum antibiotic therapy should be started. Search for a focus of infection. Examination should include the entire skin including the perineum and perianal region, indwelling IV line and other IV sites, and the mouth, teeth and sinuses. Investigations required urgently are given in Tables 35.2 and 35.3. Several antibiotic regimens have been shown to be effective in neutropenic patients without localizing signs:
Ask for advice from a haematologist.
Sepsis associated with IV drug use
Several causes of fever must be considered (Table 35.7). Right-sided endocarditis may not give rise to abnormal cardiac signs. Antibiotic therapy must cover staphylococci.
Disseminated intravascular coagulation
Disseminated intravascular coagulation (DIC) is a complication of sepsis (as well as a number of non-infective disorders). This should be suspected in patients with sepsis and also in patients with septic shock who develop purpura, prolonged oozing from puncture sites, bleeding from surgical wounds or bleeding from the gastrointestinal and respiratory tracts. Confirm by a low platelet count (<100×1012/L), prolonged prothrombin and activated partial thromboplastin times, and a high plasma concentration of fibrin degradation products. Ask advice on management from a haematologist.
If there is active bleeding or a significant invasive procedure (i.e. surgery or radiological drainage) is needed, give fresh frozen plasma and platelet concentrates, although this is not usually necessary for invasive lines in the ICU (seek senior advice). There is no conclusive evidence for the use of heparin in the treatment of DIC, but this should be considered if there is thromboembolism. Give vitamin K 10 mg IV to reverse possible vitamin K deficiency which may contribute to the coagulopathy, although there is no evidence base addressing this specific question in sepsis.
Long B, Koyfman A (2016) Clinical mimics: An Emergency Medicinefocused review of sepsis mimics. Journal of Emergency Medicine . 52, 3442.
Seymour CW, Liu VX, Iwashyna TJ, et al. (2016) Assessment of clinical criteria for sepsis: For the Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 762774.
Shankar-Hari M, Phillips GS, Levy ML, et al. (2016) Developing a new definition and assessing new clinical criteria for septic shock: For the Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 775787.
Singer M, Deutschman CS, Seymour CW, et al. (2016) The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801810.
Surviving Sepsis Campaign Guidelines. http://www.survivingsepsis.org/Guidelines/Pages/default.aspx.
Vincent J-L, Mira J-P, Antonelli M. (2016) Sepsis: older and newer concepts. Lancet Respir Med 4, 237240.